Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

HOLT-ED: Holter-monitoring in End-stage Renal Disease

NCT: NCT04876963 · COMPLETED

NCT IDNCT04876963
StatusCOMPLETED
Start Date2021-09-01
Completion2025-12-31
SponsorRigshospitalet, Denmark (OTHER)
First posted
Last updated

Brief Summary

The main objective of this prospective cohort study is to assess arrhythmia burden and glycemic variability in a multicenter cohort of patients with end-stage renal disease using a sufficient observation period in order to identify arrhythmia burden and type and characterize associations with patient characteristics and dialysis treatment, glycemic variability and subsequent risk of adverse outcomes.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑